Greetings!
Thank you for your continued interest in PAC3. Please enjoy this month's edition of the Portal. Please feel free to forward this to your friends or colleagues by clicking on this link.  |
|
PSA Screening Leads to Aggressive Treatment, Even in Older Men at Low Risk
 Researchers at the Cancer Institute of New Jersey found that 77 percent of men with a PSA level at which a prostate biopsy is often recommended-or lower underwent either complete removal of their prostate, or radiation therapy.
This treatment occurred even though more than half of these men were
considered to be at low risk of disease progression. Read more about this study here.Look for Research-tested Intervention Programs here, such as this Web-based Decision Aid for Prostate Cancer Screening program. |
|
HHS Secretary Sebelius Announces the Availability of Funding to Support the
Prevention Center for Healthy Weight
|
 FDA Votes Against Avastin Approval for Advanced Breast Cancer  Two recent studies show that the treatment, Bevacizumab (Avastin) of advanced breast cancer has limited benefits and more serious side effects than reported earlier. Women taking Avastin are encouraged to speak with their doctor. This vote does not affect patients on this treatment with other types of cancer, such as colon cancer. Read more about the FDA's decision. |
Study Shows Improved Survival of Older Non-Small Cell Lung Cancer Patients
With
the use of two chemotherapy drugs instead of one, patients between the
ages of 70 and 89 showed improved overall survival. This study began
in 2005 and the results were presented at the American Society of
Clinical Oncology (ASCO) in June. To read more about this study and others, click here.
|
|
Trials Point to More Treatment Options for Chronic Myeloid Leukemia
Short-term results from two phase III clinical trials suggest that patients
with chronic myeloid leukemia (CML) may have new options for the initial
treatment of their cancer. It's still unclear, though, whether there will be a
longer-term survival benefit from the drugs compared with the standard
first-line treatment, imatinib (GleevecŪ). Read more here.
|
CONTINUING EDUCATION
|
|
|
Cancer Control P.L.A.N.E.T. Cyber-Seminar Series: Genomics and
Cancer Control: What to Know and What to Do
Tuesday, September
14th, 2010
2:00-3:00 p.m. ET
The Centers for Disease Control and Prevention
will explain the science behind public health genomics, describe new resources
available to guide practitioners, and unveil new content available on Cancer
Control P.L.A.N.E.T. Register for this cyber-seminar here. |
4th Annual National Conference on Health Disparities
November 10-13, 2010
Marriot Hotel, PhiladelphiaThis conference will address questions related to health disparities and health literacy, poverty, education levels, safety, access to care, environmental quality, and more. Register here. |
|
PADOH: Breast Cancer Diagnostics Algorithm Training Module
 The Pennsylvania
Department of Health is proud to announce a new professional development
opportunity on Breast Cancer Diagnostic Algorithms. The training module is easily
accessible in the form of a Counter Details monograph at the Pennsylvania Medical Society's website. Continuing medical
education credits are available to physicians who complete the educational
activity. |
Nurse Oncology
Education Program - Free Video Series for Every
Nurse
Free half-hour video series to help nurses working in primary care settings update their knowledge
of adolescent and young adult cancer (ages 15-39), specifically as related to the
unique physical, emotional and practical needs of this group of
patients. Printable Certificate - .93 Contact Hours
Enroll here.
|
FUNDING OPPORTUNITIES
|
|
RFA-MD-11-001
Due Date: September 29, 2010
|
|
RFA-CA-10-010
Due date: September 16, 2010
|
Deadline: September 8, 2013 Visit PAC3's website for all funding opportunities. |
|
For PAC3 updates and contact information, please visit http://www.pac3.org/NewContacts.asp
Fox Chase Cancer Center I Office of Health Communications and Health Disparities I 510 Township Line Rd. Cheltenham, PA 19012 I August 15 2010
|
|
|
|
|
September is Prostate Cancer Awareness Month
Find out what the CDC is doing about prostate cancer or send an e-card for prostate cancer awareness.
Visit Us TOO International for events, local chapters, and resources specific to prostate cancer education.
|
PA Unveils 'High Risk' Health Insurance Plan
Pennsylvania's Department of Insurance unveiled the details
of a new "high risk" insurance plan, PA Fair Care, meant to provide health coverage for those
deemed uninsurable because of pre-existing conditions.
Highmark Blue Shield will be the only carrier
for PA Fair Care.
The department will accept applicants on a first-come, first-served
basis. Call 1-888-767-7015 or visit www.PAFairCare.com for details. Applications
will be accepted starting Aug 4.
Premiums are $283.20 a month, not
including co-pays. The program is initially expected to serve 3,500
people.
|
New Director Appointed to Wistar
Dario C. Altieri, M.D., cancer biologist is the new director of the Wistar Institute Cancer Center. Dr. Altieri will continue his laboratory's research program which is interested in how tumor cells evade the normal
processes that cause cells with genetic faults to self-destruct.
Read more here.
|
Tell Us What You Think!
In an effort to be responsive to membership, we would like to hear what information would be most useful to you in this newsletter and on the website. Please contact us with your thoughts and suggestions. |
|
